(NASDAQ: FEMY) Femasys's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 16.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.54%.
Femasys's earnings in 2025 is -$21,113,957.On average, 2 Wall Street analysts forecast FEMY's earnings for 2025 to be -$13,075,145, with the lowest FEMY earnings forecast at -$13,075,145, and the highest FEMY earnings forecast at -$13,075,145. On average, 1 Wall Street analyst forecast FEMY's earnings for 2026 to be -$9,806,359, with the lowest FEMY earnings forecast at -$9,806,359, and the highest FEMY earnings forecast at -$9,806,359.
In 2027, FEMY is forecast to generate -$6,265,174 in earnings, with the lowest earnings forecast at -$6,265,174 and the highest earnings forecast at -$6,265,174.